Ascendiant Capital Markets Issues Positive Forecast for Aemetis (NASDAQ:AMTX) Stock Price

Aemetis (NASDAQ:AMTX) had its price objective upped by Ascendiant Capital Markets from $20.00 to $21.00 in a research note published on Wednesday,Benzinga reports. They currently have a buy rating on the specialty chemicals company’s stock.

AMTX has been the topic of several other research reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Aemetis in a report on Wednesday, January 21st. Loop Capital set a $1.75 target price on shares of Aemetis in a report on Thursday, March 12th. Finally, Wall Street Zen upgraded shares of Aemetis from a “sell” rating to a “hold” rating in a report on Sunday, March 22nd. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $8.58.

Aemetis Price Performance

Shares of AMTX opened at $2.77 on Wednesday. The company has a market capitalization of $184.57 million, a PE ratio of -2.08 and a beta of 1.48. Aemetis has a one year low of $1.22 and a one year high of $3.66. The company’s fifty day moving average price is $2.05 and its 200 day moving average price is $1.97.

Aemetis (NASDAQ:AMTX) last announced its earnings results on Thursday, March 12th. The specialty chemicals company reported ($0.24) EPS for the quarter, topping the consensus estimate of ($0.28) by $0.04. The firm had revenue of $43.31 million during the quarter, compared to the consensus estimate of $72.07 million. Analysts anticipate that Aemetis will post -2.07 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Creative Planning acquired a new position in shares of Aemetis during the second quarter valued at about $30,000. Engineers Gate Manager LP acquired a new position in shares of Aemetis during the second quarter valued at about $42,000. Centiva Capital LP acquired a new position in shares of Aemetis during the third quarter valued at about $39,000. Virtu Financial LLC acquired a new position in shares of Aemetis during the fourth quarter valued at about $31,000. Finally, Tower Research Capital LLC TRC raised its position in shares of Aemetis by 206.7% during the second quarter. Tower Research Capital LLC TRC now owns 22,962 shares of the specialty chemicals company’s stock valued at $57,000 after buying an additional 15,474 shares during the last quarter. Institutional investors and hedge funds own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.